DK1017714T3 - Syntetiske peptidkonstruktioner til diagnose og behandling af paradentose forbundet med porphyromonas gingivalis - Google Patents

Syntetiske peptidkonstruktioner til diagnose og behandling af paradentose forbundet med porphyromonas gingivalis

Info

Publication number
DK1017714T3
DK1017714T3 DK98916667T DK98916667T DK1017714T3 DK 1017714 T3 DK1017714 T3 DK 1017714T3 DK 98916667 T DK98916667 T DK 98916667T DK 98916667 T DK98916667 T DK 98916667T DK 1017714 T3 DK1017714 T3 DK 1017714T3
Authority
DK
Denmark
Prior art keywords
periodontosis
diagnosis
treatment
porphyromonas gingivalis
synthetic peptide
Prior art date
Application number
DK98916667T
Other languages
English (en)
Inventor
Eric Charles Reynolds
Neil Martin O'brien-Simpson
Nada Slakeski
Original Assignee
Univ Melbourne
Csl Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Melbourne, Csl Ltd filed Critical Univ Melbourne
Application granted granted Critical
Publication of DK1017714T3 publication Critical patent/DK1017714T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/0216—Bacteriodetes, e.g. Bacteroides, Ornithobacter, Porphyromonas
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/52—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from bacteria or Archaea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55544—Bacterial toxins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031—Proteins
    • A61K2039/6037—Bacterial toxins, e.g. diphteria toxoid [DT], tetanus toxoid [TT]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Microbiology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Biotechnology (AREA)
  • Mycology (AREA)
  • General Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Cosmetics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
DK98916667T 1997-04-30 1998-04-30 Syntetiske peptidkonstruktioner til diagnose og behandling af paradentose forbundet med porphyromonas gingivalis DK1017714T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AUPO6528A AUPO652897A0 (en) 1997-04-30 1997-04-30 Synthetic peptide constructs for the diagnosis and treatment of periodontitis
PCT/AU1998/000311 WO1998049192A1 (en) 1997-04-30 1998-04-30 SYNTHETIC PEPTIDE CONSTRUCTS FOR THE DIAGNOSIS AND TREATMENT OF PERIODONTITIS ASSOCIATED WITH $i(PORPHYROMONAS GINGIVALIS)

Publications (1)

Publication Number Publication Date
DK1017714T3 true DK1017714T3 (da) 2009-01-05

Family

ID=3800820

Family Applications (1)

Application Number Title Priority Date Filing Date
DK98916667T DK1017714T3 (da) 1997-04-30 1998-04-30 Syntetiske peptidkonstruktioner til diagnose og behandling af paradentose forbundet med porphyromonas gingivalis

Country Status (12)

Country Link
US (4) US7262271B2 (da)
EP (3) EP1985625B1 (da)
JP (1) JP4276300B2 (da)
KR (1) KR100356040B1 (da)
AT (1) ATE408618T1 (da)
AU (1) AUPO652897A0 (da)
CA (4) CA2288234C (da)
DE (1) DE69840027D1 (da)
DK (1) DK1017714T3 (da)
ES (1) ES2530510T3 (da)
NZ (1) NZ500451A (da)
WO (1) WO1998049192A1 (da)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPN627595A0 (en) * 1995-10-30 1995-11-23 University Of Melbourne, The Diagnostics and treatments of periodontal disease
AUPO652897A0 (en) * 1997-04-30 1997-05-29 University Of Melbourne, The Synthetic peptide constructs for the diagnosis and treatment of periodontitis
US8129500B2 (en) 1997-12-10 2012-03-06 Csl Limited Porphyromonas gingivalis polypeptides and nucleotides
EP2283855A3 (en) * 1997-12-10 2011-05-04 CSL Limited Polypeptides et polynucleotides de phorphorymonas gingivalis
AUPP893999A0 (en) * 1999-03-01 1999-03-25 Csl Limited Synthetic peptides containing protective epitopes for the treatment and prevention of periodontitis associated with porphyromonas gingivalis
AUPQ485999A0 (en) * 1999-12-24 2000-02-03 Csl Limited P. gingivalis antigenic composition
KR100597699B1 (ko) * 2003-01-30 2006-07-07 학교법인 포항공과대학교 면역원성이 증강된 ｄｎａ 백신 조성물
JP5154935B2 (ja) 2004-09-23 2013-02-27 ザ・ユニヴァーシティ・オブ・メルボーン Ｐｏｒｐｈｙｒｏｍｏｎａｓｇｉｎｇｉｖａｌｉｓ感染を診断および治療するための抗原複合体
US20100092471A1 (en) 2006-06-27 2010-04-15 Oral Health Australia Pty Ltd Porphyromonas Gingivalis Polypeptides Useful in the Prevention of Periodontal Disease
US8241611B2 (en) 2007-07-12 2012-08-14 Oral Health Austrailia Pty. Ltd. Biofilm treatment
US20100297179A1 (en) * 2007-07-12 2010-11-25 Stuart Geoffrey Dashper Immunology Treatment for Biofilms
WO2009108716A2 (en) * 2008-02-27 2009-09-03 University Of Louisville Research Foundation Synthetic peptides
NZ591612A (en) * 2008-08-29 2012-08-31 Oral Health Australia Pty Ltd Prevention, treatment and diagnosis of p.gingivalis infection with peptides
US8140041B2 (en) * 2009-08-27 2012-03-20 Mediatek Inc. Tunable capacitive device with linearization technique employed therein
MY162557A (en) * 2010-02-26 2017-06-15 Oral Health Australia Pty Ltd Treatment or prevention of infection
BR112019005935A2 (pt) * 2016-09-29 2019-06-11 Meharry Medical College inibidores bacterianos
CN113419059B (zh) * 2021-06-30 2023-09-01 迈克生物股份有限公司 用于化学发光免疫分析方法的封闭剂

Family Cites Families (60)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4735801A (en) 1982-09-07 1988-04-05 Board Of Trustees Of Leland Stanford Jr. University Novel non-reverting salmonella live vaccines
US4837151A (en) 1980-05-19 1989-06-06 The Board Of Trustees Of The Leland Stanford Junior University, Stanford University Live vaccines comprising two mutations and foreign antigen
US5210035A (en) 1980-05-19 1993-05-11 Board Of Trustees Of Leland Stanford Jr. University Non-reventing live vaccines
US4603112A (en) 1981-12-24 1986-07-29 Health Research, Incorporated Modified vaccinia virus
JPS60142915A (ja) * 1983-12-28 1985-07-29 Lion Corp 口腔用組成物
US4693888A (en) * 1983-08-11 1987-09-15 Lion Corporation Caries-preventive composition
AU557164B2 (en) * 1984-03-30 1986-12-11 Otsuka Kagaku Kabushiki Kaisha Preparation of fibrous alkali metal titanate
JPH0699291B2 (ja) * 1985-06-14 1994-12-07 ライオン株式会社 口腔用組成物
US5013542A (en) * 1988-02-08 1991-05-07 Forsyth Dental Infirmary For Children Method to inhibit adhesion of disease-causing microorganisms to teeth
IT8820888A0 (it) * 1988-06-08 1988-06-08 Eniricerche Spa Peptidi di sintesi immunologicamente attivi per lapreparazione di vaccini antimalarici.
US5824791A (en) * 1988-09-08 1998-10-20 University Of Florida Cloned porphyromonas gingivalis genes and probes for the detection of periodontal disease
US5830710A (en) 1988-09-08 1998-11-03 University Of Florida Cloned porphyromonas gingivalis genes and probes for the detection of periodontal disease
US5665559A (en) * 1989-05-18 1997-09-09 The United States Of America As Represented By The Secretary Of The Navy Production of monoclonal antibodies to bacteroides gingivalis by hybridoma BGII, VF9/2D
DE4324859A1 (de) * 1992-07-23 1994-01-27 Lion Corp Oral verabreichbare Zusammensetzung zur Behandlung periodontaler Erkrankungen
US5536497A (en) * 1992-12-21 1996-07-16 The Research Foundation Of State University Of New York Fimbrial polypeptides useful in the prevention of periodontitis
CA2153661A1 (en) * 1993-01-12 1994-07-21 Anthony George Gristina Methods and compositions for the direct concentrated delivery of passive immunity
WO1995000110A1 (fr) * 1993-06-28 1995-01-05 Lion Corporation Composition pour la cavite buccale
US5475097A (en) * 1993-10-21 1995-12-12 University Of Georgia Research Foundation, Inc. Lysine-specific Porphyromonas gingivalis proteinase
US5523390A (en) * 1993-09-10 1996-06-04 University Of Georgia Research Foundation, Inc. Porphyromonas gingivalis arginine-specific proteinase
US6017532A (en) * 1993-09-10 2000-01-25 University Of Georgia Research Foundation, Inc. Porphyromonas gingivalis arginine-specific proteinase
EP0717747B1 (en) * 1993-09-10 2003-06-04 The University Of Georgia Research Foundation, Inc. Porphyromonas gingivalis arginine-specific proteinase coding sequences
JPH0797395A (ja) 1993-09-28 1995-04-11 Kyowa Medex Co Ltd ポルフイロモナス・ジンジバリス線毛蛋白質の配列を含有するペプチド類及びその用途
CA2176237A1 (en) * 1993-11-10 1995-05-18 Richard P. Darveau Treatment of bacterially-induced inflammatory diseases
DE69527514T2 (de) 1994-03-29 2003-04-03 Meito Sangyo Kk Gen eines zelloberflächenpolypeptids
FI98961C (fi) * 1994-08-26 1997-09-10 Medix Biochemica Ab Oy Menetelmät ja määritysvälineet parodontaalisairauden aktiivisuuden ja/tai peri-implantiitin ja/tai niiden kohonneen riskin diagnosoimiseksi
US20030157637A1 (en) * 1998-09-15 2003-08-21 The University Of Melbourne Diagnostics and treatments of periodontal disease
AUPN627595A0 (en) * 1995-10-30 1995-11-23 University Of Melbourne, The Diagnostics and treatments of periodontal disease
US6129917A (en) 1996-03-22 2000-10-10 The University Of Georgia Research Foundation, Inc. Immunogenic compositions comprising porphyromonas gingivalis proteins and/or peptides and methods
AUPN901296A0 (en) * 1996-03-29 1996-04-26 University Of Melbourne, The Porphyromonas gingivalis antigens for the diagnosis and treatment of periodontitis
US7341727B1 (en) 1996-05-03 2008-03-11 Emergent Product Development Gaithersburg Inc. M. catarrhalis outer membrane protein-106 polypeptide, methods of eliciting an immune response comprising same
AUPO652897A0 (en) * 1997-04-30 1997-05-29 University Of Melbourne, The Synthetic peptide constructs for the diagnosis and treatment of periodontitis
US8129500B2 (en) 1997-12-10 2012-03-06 Csl Limited Porphyromonas gingivalis polypeptides and nucleotides
AUPP083997A0 (en) 1997-12-10 1998-01-08 Csl Limited Porphyromonas gingivalis nucleotides
US6444799B1 (en) 1997-12-31 2002-09-03 Csl Limited P. gingivalis polynucleotides and uses thereof
AUPP893999A0 (en) 1999-03-01 1999-03-25 Csl Limited Synthetic peptides containing protective epitopes for the treatment and prevention of periodontitis associated with porphyromonas gingivalis
US6833262B1 (en) * 1999-04-21 2004-12-21 University Of Georgia Research Foundation, Inc. Polypeptide having amidolytic activity for a serpin
EP1210182A1 (en) 1999-05-12 2002-06-05 The General Hospital Corporation Permeabilizing biofilms
GB9913437D0 (en) 1999-06-09 1999-08-11 Medical Res Council Fusion proteins
AUPQ485999A0 (en) 1999-12-24 2000-02-03 Csl Limited P. gingivalis antigenic composition
AUPQ718200A0 (en) 2000-04-28 2000-05-25 Csl Limited Porphyromonas gingivalis recombinant proteins and truncations
US20020110843A1 (en) * 2000-05-12 2002-08-15 Dumas David P. Compositions and methods for epitope mapping
AU2002225954A1 (en) * 2000-11-08 2002-05-21 The University Of Georgia Research Foundation, Inc. Dipeptidylpeptidases and methods of use
US6726898B2 (en) 2000-11-17 2004-04-27 Gary R. Jernberg Local delivery of agents for disruption and inhibition of bacterial biofilm for treatment of periodontal disease
US20030083287A1 (en) 2000-11-30 2003-05-01 Burgess Nicola A. ginS
US20020192206A1 (en) * 2001-05-05 2002-12-19 Kozarov Emil V. Methods and compositions for angioproliferative disorder treatment
AUPR575401A0 (en) 2001-06-18 2001-07-12 Unisearch Limited Method of causing sloughing
JP2003192616A (ja) 2001-12-27 2003-07-09 Univ Nihon 歯周病用ｄｎａワクチン
JP2003286191A (ja) 2002-03-27 2003-10-07 Univ Nihon 歯周病用粘膜免疫ワクチン
US20070036734A1 (en) 2003-03-17 2007-02-15 Kirin Beer Kabushiki Kaisha Therapeutic agent for periodontal disease
WO2005019249A2 (en) 2003-08-15 2005-03-03 University Of Florida Identification of porphyromonas gingivalis virulence polynucleotides for diagnosis, treatment, and monitoring of periodontal diseases
US7424370B2 (en) 2004-02-06 2008-09-09 Council Of Scientific And Industrial Research Computational method for identifying adhesin and adhesin-like proteins of therapeutic potential
US20070098649A1 (en) 2004-03-22 2007-05-03 The Board Of Trustees Of The University Of Illinois Method and composition for controlling oral pathogens
JP5154935B2 (ja) 2004-09-23 2013-02-27 ザ・ユニヴァーシティ・オブ・メルボーン Ｐｏｒｐｈｙｒｏｍｏｎａｓｇｉｎｇｉｖａｌｉｓ感染を診断および治療するための抗原複合体
WO2008016385A2 (en) 2006-01-20 2008-02-07 The University Of Washington Deacylase polypeptides, deacylase polynucleotides, and methods of use thereof
US20100092471A1 (en) 2006-06-27 2010-04-15 Oral Health Australia Pty Ltd Porphyromonas Gingivalis Polypeptides Useful in the Prevention of Periodontal Disease
WO2008124646A2 (en) 2007-04-06 2008-10-16 The Government Of The U.S.A, As Represented By The Secretary, Dept. Of Health And Human Services Use of amyloid proteins as vaccine scaffolds
US8241611B2 (en) 2007-07-12 2012-08-14 Oral Health Austrailia Pty. Ltd. Biofilm treatment
US20100297179A1 (en) 2007-07-12 2010-11-25 Stuart Geoffrey Dashper Immunology Treatment for Biofilms
KR100948094B1 (ko) 2007-12-26 2010-03-16 주식회사 하이닉스반도체 데이터 출력 제어회로
NZ591612A (en) 2008-08-29 2012-08-31 Oral Health Australia Pty Ltd Prevention, treatment and diagnosis of p.gingivalis infection with peptides

Also Published As

Publication number Publication date
KR100356040B1 (ko) 2002-10-18
CA2720332C (en) 2013-07-23
NZ500451A (en) 2001-02-23
EP1985625B1 (en) 2014-11-12
EP1017714A1 (en) 2000-07-12
DE69840027D1 (de) 2008-10-30
CA2288234C (en) 2008-11-18
CA2288234A1 (en) 1998-11-05
US20130309179A1 (en) 2013-11-21
US20110268670A1 (en) 2011-11-03
CA2639048A1 (en) 1998-11-05
EP1985625A2 (en) 2008-10-29
ES2530510T3 (es) 2015-03-03
CA2815903A1 (en) 1998-11-05
US20080124284A1 (en) 2008-05-29
US7749502B2 (en) 2010-07-06
US8841420B2 (en) 2014-09-23
EP1017714B1 (en) 2008-09-17
EP1985625A3 (en) 2009-02-18
KR20010020417A (ko) 2001-03-15
EP2246361A1 (en) 2010-11-03
AUPO652897A0 (en) 1997-05-29
ATE408618T1 (de) 2008-10-15
CA2720332A1 (en) 1998-11-05
US8431688B2 (en) 2013-04-30
CA2639048C (en) 2012-12-11
WO1998049192A1 (en) 1998-11-05
US20040005276A1 (en) 2004-01-08
JP4276300B2 (ja) 2009-06-10
US7262271B2 (en) 2007-08-28
JP2002511847A (ja) 2002-04-16
EP1017714A4 (en) 2005-02-23

Similar Documents

Publication Publication Date Title
DK1017714T3 (da) Syntetiske peptidkonstruktioner til diagnose og behandling af paradentose forbundet med porphyromonas gingivalis
HUP9801240A2 (en) Oral compositions
FR10C0016I2 (fr) Procedes et compositions s'appliquant au traitement de la glomerulonephrite
IL189629A0 (en) Compositions containing human ctla-4 antibodies
MY101842A (en) Treatment of oral diseases.
ES2059422T3 (es) Composiciones desinfectantes.
MXPA03001645A (es) Composiciones y metodos para el diagnostico y tratamiento de tumores.
EP1539228A4 (en) NEW COMPOSITION AND METHOD FOR THE TREATMENT OF IMMUNE DISEASES
AR020169A1 (es) Uso de una bacteria lactica para la preparacion de composiciones orales, las composiciones para la salud de la boca que contienen dicha bacteria lactica yel metodo para seleccionar bacterias lacticas de aplicacion en dicho uso
BR0015698A (pt) Composições e métodos para tratamento de doenças alérgicas
DE60132444D1 (de) Behandlung von reizkolon-syndrom oder -krankheit
DE69516406T2 (de) Mundspülungsmittel
DE69836464D1 (de) Orale Zusammensetzung für die Behandlung von übelriechendem Atem
MXPA03001643A (es) Composiciones y metodos para el diagnostico y tratamiento de tumores.
ZA972757B (en) Porphyromonas gingivalis antigents for the diagnosis and treatment of periodontitis.
HUP9904217A2 (hu) Fehérítőt, szulfamidsavat és egy polikarboxilát polimert tartalmazó tisztító készítmény
DE69008153T2 (de) Mundwasser und verfahren zur beseitigung des zahnsteins.
GB9501826D0 (en) Polypeptide fragments
IL111805A0 (en) Pharmaceutical compositions comprising dimeticone for the treatment of aphthae
DE69913380D1 (de) Zusammensetzung zur behandlung von periodontalen erkrankungen
HU9801705D0 (en) Streptococcus equi vaccine
DE69519040D1 (de) Zusammensetzung zur hygiene,prophylaxe und behandlung der mundhöhle
DE69119588T2 (de) Verwendung von ketorolac zur behandlung von periodontitis
ID26132A (id) Pembuatan untuk pengobatan dari gangguan fungsi ereksi
MXPA03001644A (es) Composiciones y metodos para el diagnostico y tratamiento de tumor.